Francois Mallet
35Patents
9h-index
55Co-inventors
78Inventor score
Filing activity: Jun 25, 1990 → Jun 28, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5849547A | Method for nucleic acid amplification by transcription using displacement, and reagents and kit therefor | Chemistry; Metallurgy | 148 | Expired |
| US5874260A | Oligonucleotide which can be used as primer in a method of amplification based on a replication accompanied by strand displacement | Chemistry; Metallurgy | 86 | Expired |
| US5695926A | Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support | Chemistry; Metallurgy | 73 | Expired |
| US5744308A | Chimera oligonucleotide and its utilization for obtaining transcripts of a nucleic acid | Chemistry; Metallurgy | 52 | Expired |
| US6218151A | Method for nucleic acid amplification by transcription using displacement, and reagents and kit therefor | Chemistry; Metallurgy | 40 | Expired |
| US5654143A | RNA amplification method requiring only one manipulation step | Chemistry; Metallurgy | 16 | Expired |
| US5891681A | Modified promoter for RNA polymerase, its preparation and its applications | Chemistry; Metallurgy | 15 | Expired |
| US6342383B1 | Cell lines and viral isolates associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5800980A | Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6660533B2 | Attaching a biological molecule to a support surface | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6184025A | Viral isolates associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5871996A | Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5962217A | MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5871745A | Multiple sclerosis related virus | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7442550B1 | Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein | Chemistry; Metallurgy | 3 | Expired |
| US6632615B2 | Method for isolating a target biological material, capture phase, detecting phase and reagent containing them | Chemistry; Metallurgy | 3 | Expired |
| USRE39031E1 | RNA amplification method requiring only one manipulation step | General | 2 | Expired |
| US5817465A | RNA amplification method requiring only one manipulation step | Chemistry; Metallurgy | 2 | Expired |
| US5252465A | Avian erythroblastosis virus vectors for integration and expression of heterologous genes in avian cells | Chemistry; Metallurgy | 1 | Expired |
| US8088910B2 | Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region | Chemistry; Metallurgy | 0 | Active |
| US10240213B2 | Method for in vitro diagnosis or prognosis of testicular cancer | Chemistry; Metallurgy | 0 | Active |
| US11519042B2 | Method for the diagnosis or prognosis, in vitro, of lung cancer | Chemistry; Metallurgy | 0 | Active |
| US11473147B2 | Method for the diagnosis or prognosis, in vitro, of testicular cancer | Chemistry; Metallurgy | 0 | Active |
| US11459605B2 | Method for the diagnosis or prognosis, in vitro, of prostate cancer | Chemistry; Metallurgy | 0 | Active |
| US11453920B2 | Method for the in vitro diagnosis or prognosis of ovarian cancer | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.